ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1616

Comparison of Conventional and Wholebody Magnetic Resonance Imaging for Assessing Inflammation and Structural Damage in Psoriatic Arthritis and Axial Spondyloarthritis

René Panduro Poggenborg1, Susanne Juhl Pedersen2, Iris Eshed3, Inge Juul Sørensen4, Ole Rintek Madsen5, J.M. Møller6 and Mikkel Østergaard7, 1Department of Rheumatology, Copenhagen University Hospital in Glostrup, Copenhagen, Denmark, 2Dept. of Rheumatology, Copenhagen Center for Arthritis Research, Copenhagen, Denmark, 3Department of Radiology, Sheba Medical Center, Tel Hashomer, Israel, 4Department of Rheumatology, Glostrup Hospital, Copenhagen, Denmark, 5Department of Rheumatology, Copenhagen University Hospital in Gentofte, Copenhagen, Denmark, 6Department of Radiology, Copenhagen University Hospital in Herlev, Copenhagen, Denmark, 7Copenhagen University Hospital Glostrup, Glostrup, Denmark

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Magnetic resonance imaging (MRI), psoriatic arthritis and spondylarthropathy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Imaging of Rheumatic Diseases II: Magnetic Resonance Imaging

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Wholebody magnetic resonance imaging (WBMRI) is a new imaging modality where patients are scanned from “head to toe” in one single scan, but with a lower resolution than conventional MRI (cMRI). The purpose was to investigate the ability of WBMRI for detection of inflammation and structural damage in psoriatic arthritis (PsA) and spondyloarthritis (SpA), and to compare findings with dedicated cMRI.

Methods:

Patients with clinically active peripheral PsA (Moll and Wright, n=19) or axial SpA (ESSG, n=19) and healthy subjects (HS, n=12) were included. WBMRI was assessed for synovitis, bone marrow oedema (BME), and bone erosions at sites included in the 78-tender joint count (TJC). Furthermore, WBMRI fat infiltration, BME and bone erosions were evaluated in 23 discovertebral units (DVUs) and in sacroiliac joints (SIJ) (8 quadrants). Wholebody imaging were performed on a 3 tesla MRI unit with built-in bodycoil (sagittal and coronal T1-weighted pre/post-contrast and STIR sequences), and 1½ tesla cMRI (SpA and HS: of spine and SIJ; PsA and HS: unilateral hand) were performed using T1w pre/post-contrast and STIR sequences. The PsAMRIS-hand method (1) was used for scoring synovitis in finger joints in PsA and HS.

Results:

Characteristics median (range): PsA/SpA/HS age 49 (23-79)/42 (26-61)/32 (20-61) yrs. PsA/SpA disease duration: 4(0-34)/17(5-48) yrs; 78-TJC: 11(3-65)/3(0-17), 76-swollen joint count: 5(0-20)/1(0-5), and BASDAI score 45(9-85)/55(2-93) mm.

By WBMRI more than 97% of spinal DVUs and SIJ quadrants could be evaluated, whereas evaluation of peripheral joints for synovitis and BME was possible in 66 % and 55 % of joints, respectively. It was possible to evaluate 56% of the finger joints with WBMRI. BME assessed in 78 joints by WBMRI was significantly more frequent in PsA/SpA than in HS (p<0.05, see table). We found no statistically significant difference between groups in WBMRI synovitis assessed in all 78 joints, or only assessed in hand joints. In contrast, PsAMRIS-hand synovitis (scored 0-36) assessed by cMRI was higher in PsA than HS (P<0.0005).

The table shows median (range) scores of WBMRI and cMRI findings in joints, DVUs, and SIJ quadrants.   

 

PsA

SpA

HS

WBMRI

cMRI

WBMRI

cMRI

WBMRI

cMRI

78-joint: Synovitis (0-78)

12 (1-45)

 –

10 (0-28)

–

10 (2-40)

–

78-joint: BME (0-78)

4 (0-25)*

2 (0-15)*

–

2 (0-5)

–

Spine: BME (0-23)

2 (0-6)*

1 (0-11)

1 (0-8)

0.5 (0-2)

0 (0-3)

Spine: Fat infiltration (0-23)

0 (0-7)

1 (0-18)

2 (0-20)*

0 (0-6)

0 (0-3)

Spine: Bone erosion (0-23)

0 (0-1)

0 (0-0)

0 (0-2)*

0 (0-1)

0 (0-1)

SIJ: BME (0-8)

0 (0-2)

0 (0-8)*

0 (0-8)*

0 (0-2)

0 (0-2)

SIJ: Fat infiltration (0-8)

0 (0-8)

0 (0-8)*

2 (0-8)*

0 (0-4)

0 (0-8)

SIJ: Bone erosion (0-8)

0 (0-6)

0 (0-8)

2 (0-8)*

0 (0-8)

0 (0-4)

Mann-Whitney test was used for comparing PsA/SpA with HS. *P<0.05.

Significant correlation was found between WBMRI and cMRI in spinal/SIJ fat infiltration (Spearman’s rho: 0.52/0.52, both P<0.005), SIJ BME (0.78, P<0.0001), and SIJ bone erosion (0.72, P<0.0001). In PsA, the sensitivity, specificity and accuracy of WBMRI synovitis in the hand were 35 %, 80% and 66 %, when cMRI was considered the gold standard reference.

Conclusion:

WBMRI showed higher scores of peripheral and axial BME in PsA and SpA, compared to HS. Highly significant correlation was found between WBMRI and conventional MRI assessments of axial BME, fat infiltration and bone erosions. WBMRI has potential value for assessing axial and peripheral disease manifestations in PsA and SpA.

Ref: 1) Østergaard, JRheum 2009


Disclosure:

R. P. Poggenborg,
None;

S. J. Pedersen,
None;

I. Eshed,
None;

I. J. Sørensen,
None;

O. R. Madsen,
None;

J. M. Møller,
None;

M. Østergaard,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/comparison-of-conventional-and-wholebody-magnetic-resonance-imaging-for-assessing-inflammation-and-structural-damage-in-psoriatic-arthritis-and-axial-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology